Wintac Ltd.
| BSE: 524758 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE812C01016 |
| BSE 00:00 | 17 Dec | Wintac Ltd |
| NSE 05:30 | 01 Jan | Wintac Ltd |
| OPEN | 345.00 |
| PREVIOUS CLOSE | 341.60 |
| VOLUME | 4199 |
| 52-Week high | 345.00 |
| 52-Week low | 165.25 |
| P/E | 194.09 |
| Mkt Cap.(Rs cr) | 342 |
| Buy Price | 341.60 |
| Buy Qty | 10000.00 |
| Sell Price | 343.75 |
| Sell Qty | 83.00 |
Wintac Ltd. (WINTAC) - Net Sales
Market Cap
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
| Aurobindo Pharma | 958.05 | 3.40 | 0.36 | 13266.48 |
| Cipla | 954.20 | -5.80 | -0.60 | 12659.15 |
| Sun Pharma.Inds. | 669.25 | -2.00 | -0.30 | 12531.93 |
| Dr Reddy's Labs | 5290.60 | 11.00 | 0.21 | 11850.40 |
| Lupin | 1158.55 | 1.15 | 0.10 | 11025.66 |
| Apollo Hospitals | 3259.25 | 21.60 | 0.67 | 9794.50 |
| Glenmark Pharma. | 644.70 | 3.45 | 0.54 | 6712.63 |
| Alkem Lab | 3153.10 | 29.80 | 0.95 | 6677.08 |
| Cadila Health. | 630.00 | 0.60 | 0.10 | 6347.40 |
| Torrent Pharma. | 2940.70 | 22.20 | 0.76 | 6168.44 |
| Divi's Lab. | 4275.15 | 45.85 | 1.08 | 5310.57 |
| Alembic Pharma | 997.70 | -3.00 | -0.30 | 5051.44 |
| Ipca Labs. | 1998.35 | -10.65 | -0.53 | 4337.82 |
| Piramal Enterp. | 2471.35 | 148.45 | 6.39 | 4219.19 |
| Abbott India | 16482.25 | -73.15 | -0.44 | 4093.14 |
| Glaxosmi. Pharma | 1512.65 | -22.80 | -1.48 | 3224.68 |
| Jubilant Pharmo | 745.55 | -1.15 | -0.15 | 3139.90 |
| Sanofi India | 7657.20 | 18.55 | 0.24 | 2901.90 |
| Laurus Labs | 612.90 | 10.60 | 1.76 | 2797.34 |
| Ajanta Pharma | 1968.75 | -26.25 | -1.32 | 2718.59 |
Quick Links for Wintac:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
